72 reports

Global Diagnostic Imaging Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in Diagnostic Imaging dealmaking ##. ##.

  • Diagnostic Imaging
  • Health Services
  • Hospital
  • United States
  • Demand

THIS INDUSTRY INCLUDES ESTABLISHMENTS THAT MANUFACTURE DRUGS SUCH AS CARDIOVASCULAR DRUGS, GASTROINTESTINAL DRUGS, GENITO-URINARY DRUGS, HEMATOLOGY DRUGS AND OTHER DRUGS USED TO TREAT CARDIOVASCULAR DISEASES, RARE GENETIC DISORDERS, INFECTIONS, METABOLIC DISORDERS, CANCERS, AND RES

  • Diagnostic Imaging
  • World
  • Demand
  • Market Size
  • Becton Property Group
  • BY PRODUCT
  • BY END-USER

The diagnostic devices like x-ray, CT, ultrasound, MRI are used to diagnose diseases mainly caused due to high blood pressure, diabetes, genetic disorders, smoking, hypertension.

  • Diagnostic Imaging
  • World
  • Market Size
  • GE Healthcare Limited
  • Hitachi, Ltd.

In addition, the use of ototoxic medications such as certain types of chemotherapies and antibiotics, certain nutritional deficiencies, industrial solvents, genetic disorders, and aging also lead to hearing impairment.

  • Diagnostic Imaging
  • Ear, Nose, And Throat Medicine
  • Carl Zeiss AG
  • Danaher Corporation
  • Olympus Corporation

Moreover, unlike tissue biopsies, which are obtained from only one tumor region, a liquid biopsy can better reflect the genetic profile of all tumor sub-clones present in the patient.

  • Biopsy
  • Diagnostic Imaging
  • Danaher Corporation
  • MDxHealth SA
  • OPKO Health, Inc.

The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person' s chance of developing or passing on a genetic disorder.

  • Diagnostic Imaging
  • China
  • Demand
  • Forecast
  • Market Size

Increasing incidence of genetic diseases, such as lymphoma, solid tumors, leukemia, autism, and other developmental syndromes, is also expected to boost adoption.

  • Diagnostic Imaging
  • United States
  • Demand
  • 1.1 Colorectal Cancer

Most colorectal cancers are due to old age and lifestyle factors with only a small number of cases with underlying genetic disorders.

  • Colorectal Cancer
  • Diagnostic Imaging
  • United States
  • Epigenomics AG
  • Exact Sciences Corp.

THE RESULTS OF A GENETIC TEST CAN CONFIRM OR RULE OUT A SUSPECTED GENETIC CONDITION OR HELP DETERMINE A PERSON' S CHANCE OF DEVELOPING OR PASSING ON A GENETIC DISORDER.

  • Diagnostic Imaging
  • China
  • Demand
  • Market Size
  • Hitachi, Ltd.
  • Market drivers

Neurological disorders have been increasing due to changing lifestyle, genetic disorders, among other factors.

  • Diagnostic Imaging
  • United States
  • World
  • Forecast
  • Market Size

For instance, in 2015, the Centre for Disease and Control (CDC) estimated that around ##% of the population in the US has at least one of the three key risk factors for heart disease that includes high blood pressure, high cholesterol, and smoking.

  • Diagnostic Imaging
  • GE Healthcare Limited
  • Koninklijke Philips N.V.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Toshiba Corporation

BRUGADA SYNDROME IS A GENETIC DISEASE THAT PREDISPOSES TO HEART ATTACK OR SUDDEN DEATH DUE TO MALIGNANT VENTRICULAR TACHYARRHYTHMIA.

  • Diagnostic Imaging
  • Southern Europe
  • Spain
  • Market Size
  • Boston Scientific Corporation

DUCHENNE MUSCULAR DYSTROPHY IS A GENETIC MUSCLE WASTING DISEASE THAT BEGINS IN CHILDHOOD AND MAINLY AFFECTS BOYS.

  • Colorectal Cancer
  • Diagnostic Imaging
  • Northern Europe
  • United Kingdom
  • Market Size

NRG (U. S. ) manufactures P-##, Cu-## and Ho-## for the treatment of excess red blood cells, genetic diseases (copper metabolism) and liver cancer respectively.

  • Colorectal Cancer
  • Diagnostic Imaging
  • World
  • Market Size
  • Lantheus Medical Imaging, Inc.

Financial Overview the company is working on GPU-based deep learning to understand how genetic variations can lead to disease.

  • Diagnostic Imaging
  • World
  • DexCom, Inc.
  • Ethicon, Inc.
  • Samsung Electronics Co., Ltd.

Also, increase in chronic and genetic diseases supported the IVD segment growth as these diseases require proper lab tests for diagnosis.

  • Colorectal Cancer
  • Diagnostic Imaging
  • Medical Device
  • World
  • Market Size

In addition the research group has worked with Alzheimer' s disease consortiums to look at genetic overlap between stroke and Alzheimer' s disease.

  • Diagnostic Imaging
  • World
  • Market Size
  • Compumedics Limited
  • Medtronic, Inc.

It is also used in BMD evaluation and regulation of medications taken for corticosteroid treatment, eating disorders, amenorrhea cancer, and genetic disorders as they may cause bone deterioration.

  • Diagnostic Imaging
  • World
  • Market Size
  • GE Healthcare Limited
  • Hologic, Inc.
  • 05. Introduction
  • 06.1 Understanding the Disease

The risk factors for colorectal cancer include an unhealthy lifestyle, age, genetic disorders, family history, and inflammatory bowel disease.

  • Colorectal Cancer
  • Diagnostic Imaging
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.

Looking at disease at the genetic and molecular level has, in effect, created new categories of disease.

  • Colorectal Cancer
  • Diagnostic Imaging
  • United States
  • Market Size
  • Illumina, Inc.

Looking at disease at the genetic and molecular level has, in effect, created new categories of disease.

  • Colorectal Cancer
  • Diagnostic Imaging
  • United States
  • Market Size
  • Illumina, Inc.
  • Disease overview

The risk factors for this cancer include age, family history, unhealthy lifestyle, genetic disorders, and inflammatory bowel disease.

  • Colorectal Cancer
  • Diagnostic Imaging
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Sanofi S.A.

Deal Rationale Sarepta Therapeutics Inc (Sarepta) is discovers and develops unique RNA-targeted therapeutics, gene therapy and other genetic medicine approaches to treat rare neuromuscular diseases.

  • Diagnostic Imaging
  • Pharmaceutical
  • Therapy
  • United States
  • Catabasis Pharmaceuticals, Inc.

" The results from our genetic testing of various cancer markers provides strong evidence of a positive effect against aggressive tumor types, like pancreatic cancer.

  • Biopharmaceutical
  • Colorectal Cancer
  • United States
  • World
  • Product Initiative

According to the American Heart Association Heart Disease and This report will cover: ES-## U. S.

  • Diagnostic Imaging
  • United States
  • Forecast
  • GE Healthcare Limited
  • Stryker Corporation

Becker muscular dystrophy (BMD) is one of type of muscular dystrophy, a group of genetic, degenerative diseases primarily affecting voluntary muscles.

  • Diagnostic Imaging
  • Neurological Disorder
  • Therapy
  • United States
  • Product Initiative

Furthermore, one in every ## people aged ## and above in Taiwan has Alzheimer' s disease (Source: Taipei Times).

  • Diagnostic Imaging
  • Neurology
  • North America
  • United States
  • Market Size

THROUGH MASSIVELY PARALLEL SEQUENCING, THIS TECHNOLOGY BRINGS ABOUT FASTER IDENTIFICATION OF GENETIC DISEASES IN SPECIFIC POPULATIONS OR TISSUE TYPES.

  • Colorectal Cancer
  • Diagnostic Imaging
  • Molecular Diagnostics
  • North America
  • United States

Unlike many " recreational" consumer genetic tests currently available in Asia, these are medical evidence-based genetic tests designed to help physicians screen, diagnose and manage genetic disorders.

  • Colorectal Cancer
  • Diagnostic Imaging
  • East Asia
  • Market Size
  • PerkinElmer, Inc.

OHSU conducts research in disease areas including cancer, rare genetic disorders, diseases of the central nervous system, cardiovascular-related research and infectious disease.

  • Colorectal Cancer
  • Diagnostic Imaging
  • Medical Device
  • United States
  • Verisante Technology, Inc.